Skip to content
Menu

Jyong Biotech Ltd. MENS

Full chart Compare
Set alert

Price alert · MENS

All alert types
1.45 USD -0.30 (-17.14%)

Regular-session close

1.74 +0.29 +20.00%

After hours · Nov 20, 4:00 PM ET

1.44 Day range 1.77
1.45 52-week range 35.40
YTD
-63.29%
1 year
-95.58%

 

No chart data for this range yet.
Market cap
110.24M
EPS (ttm)
-0.06
Shares out
76.03M
YTD return
-63.29%
1-year return
-95.58%
50-day average
40.49
Volume
90.89K
Avg volume
43.09K
Open
1.62
Previous close
1.75
Day's range
1.44 – 1.77
52-week range
1.45 – 35.40

Key statistics

200-day average
36.26
Enterprise value
1.16B
Free cash flow
-1.73M
Total cash
98.00K
Total debt
18.14M
Short % of float
0.45%

Fundamental scorecard

1 of 25 checks passed on MENS’s reported financials

ValueGrowthProfitabilityHealthDividend

1of 25 checks passed

  • Value 0 of 5
  • Growth 0 of 5
  • Profitability 0 of 5
  • Financial health 1 of 5
  • Dividend 0 of 5

Statements to Dec 31, 2025.

Financials — quick view

All financials
MENS Revenue — quarterly 47.68M
MENS Net income — quarterly 2.69M
MENS EPS — quarterly 0.26

About Jyong Biotech Ltd.

Jyong Biotech Ltd., a science-driven biotechnology company, develops and commercializes plant-derived drugs for the treatment of urinary system diseases in the United States, the European Union, and Asia. It develops MCS-2 for the treatment of benign prostate hyperplasia/lower urinary tract symptoms; PCP for treating prostate cancer; and interstitial cystitis (IC) for the treatment of IC/bladder pain syndrome. The company was founded in 2002 and is headquartered in New Taipei City, Taiwan.

Sector
Healthcare
Industry
Biotechnology
Country
Taiwan
Website
jyongbio.com

News

No recent headlines

Headlines appear here as they are published.

Your note

Sign in to keep a note on MENS — it syncs with the Stock Master app.

Institution ownership

MENS institution ownership
Holder% heldSharesValueReported
Geode Capital Management, LLC0.07%53,844157.22KSep 29, 2025
HRT Financial LP0.03%20,81960.79KSep 29, 2025
Millennium Management Llc0.02%13,01338.00KSep 29, 2025
Citadel Advisors Llc0.02%12,64136.91KSep 29, 2025
BNP Paribas Financial Markets0.00%1,6984.96KSep 29, 2025
UBS Group AG0.00%5371.57KSep 29, 2025

Fund ownership

MENS fund ownership
Holder% heldSharesValueReported
Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund0.05%35,802104.54KSep 29, 2025
Fidelity Commonwealth Trust-Fidelity Nasdaq Composite Index ETF0.02%18,04252.68KSep 29, 2025